| Prev Close | 11.56 |
| Day Low/High | 0.00 / 0.00 |
| 52 Wk Low/High | 4.20 / 11.98 |
| Avg Volume | 346.70K |
| Exchange | NASDAQ |
| Shares Outstanding | 42.99M |
| Market Cap | 503.03M |
| EPS | -1.00 |
| P/E Ratio | N/A |
| Div & Yield | N.A. (N.A) |
Latest News
GenMark Diagnostics To Present At The 36th Annual Canaccord Genuity Growth Conference
GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, announced today that Hany Massarany, President and Chief Executive Officer, will present at the 36th...
GenMark Diagnostics Schedules Second Quarter 2016 Financial Results Conference Call For July 28, 2016
GenMark Diagnostics, Inc. (NASDAQ:GNMK) today announced that it plans to release its second quarter earnings results after market close on Thursday, July 28, 2016.
GenMark Achieves CE Mark For Its EPlex® Sample-to-Answer System
GenMark Diagnostics, Inc. (Nasdaq:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced it has achieved CE Mark under the European In-Vitro Diagnostic Devices...
Insider Trading Alert - GNMK, CLRO And ADSK Traded By Insiders
Stocks with insider trader activity include GNMK, CLRO and ADSK
GenMark Diagnostics To Present At The William Blair 36th Annual Growth Stock Conference
GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, announced today that Hany Massarany, President and Chief Executive Officer, will present at the...
Commit To Purchase GenMark Diagnostics At $7.50, Earn 31.2% Annualized Using Options
Investors eyeing a purchase of GenMark Diagnostics, Inc. stock, but cautious about paying the going market price of $8.63/share, might benefit from considering selling puts among the alternative strategies at their disposal.
Short Interest In GenMark Diagnostics Decreases By 11.2%
The most recent short interest data has been released for the 04/29/2016 settlement date, which shows a 558,337 share decrease in total short interest for GenMark Diagnostics, Inc. , to 4,404,251, a decrease of 11.25% since 04/15/2016.
Insider Trading Alert - PTC, EVR And GNMK Traded By Insiders
Stocks with insider trader activity include PTC, EVR and GNMK
GenMark Reports First Quarter 2016 Results
GenMark Diagnostics, Inc. (Nasdaq:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced financial results for the first quarter ended March 31, 2016.
GenMark Diagnostics Schedules First Quarter 2016 Financial Results Conference Call For May 3, 2016
GenMark Diagnostics, Inc. (NASDAQ:GNMK) today announced that it plans to release its first quarter earnings results after market close on Tuesday, May 3, 2016.
Insider Trading Alert - GNMK, NEWT And ETM Traded By Insiders
Stocks with insider trader activity include GNMK, NEWT and ETM
Insider Trading Alert - GNMK, LKQ And USNA Traded By Insiders
Stocks with insider trader activity include GNMK, LKQ and USNA
Insider Trading Alert - GNMK, DIN And COR Traded By Insiders
Stocks with insider trader activity include GNMK, DIN and COR
GenMark Diagnostics Enters Oversold Territory (GNMK)
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.
GenMark Reports Fourth Quarter And Full Year 2015 Results
GenMark Diagnostics, Inc. (Nasdaq:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced financial results for the fourth quarter and year ended December 31, 2015.
GNMK: Insiders vs. Shorts
The most recent short interest data was recently released by the NASDAQ for the 01/29/2016 settlement date, and GenMark Diagnostics, Inc. is one of the most shorted stocks of the Russell 3000, based on 22.70 "days to cover" versus the median component at 4.92.
Insider Trading Alert - GNMK, ENSG And USNA Traded By Insiders
Stocks with insider trader activity include GNMK, ENSG and USNA
Relative Strength Alert For GenMark Diagnostics
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.
GenMark Announces Preliminary Q4 Financial Results And Initiation Of EPlex™ Analytical Studies
GenMark Diagnostics, Inc. (Nasdaq:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today reported preliminary fourth quarter 2015 results.
GenMark Diagnostics To Present At The 2016 J.P. Morgan Healthcare Conference
GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, will present at the 2016 J.
Commit To Purchase GenMark Diagnostics At $7.50, Earn 18.4% Annualized Using Options
Investors eyeing a purchase of GenMark Diagnostics, Inc. shares, but tentative about paying the going market price of $7.89/share, might benefit from considering selling puts among the alternative strategies at their disposal.
GNMK: Insiders vs. Shorts
The most recent short interest data was recently released by the NASDAQ for the 10/30/2015 settlement date, and GenMark Diagnostics, Inc. is one of the most shorted stocks of the Russell 3000, based on 6.94 "days to cover" versus the median component at 5.62.
Insider Trading Alert - GNMK, FN And CRM Traded By Insiders
Stocks with insider trader activity include GNMK, FN and CRM
Insider Trading Alert - NWBI, GNMK And FTK Traded By Insiders
Stocks with insider trader activity include NWBI, GNMK and FTK
GenMark Diagnostics Reports Q3 Financial Results
GenMark Diagnostics, Inc. (Nasdaq:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today reported third quarter 2015 financial results.
GenMark Diagnostics is Now Oversold (GNMK)
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.
GenMark Diagnostics Schedules Third Quarter 2015 Financial Results Conference Call For October 27, 2015
GenMark Diagnostics, Inc. (NASDAQ:GNMK) today announced that it plans to release its third quarter earnings results after market close on Tuesday, October 27, 2015.
Oversold Conditions For GenMark Diagnostics (GNMK)
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.
